|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,981.00 JPY | +1.02% |
|
-3.53% | +1.74% |
| Fiscal Period: February | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.35 | 2.76 | 2.06 | 3.29 | 3.21 | |||||
Return on Total Capital | 3.02 | 3.5 | 2.6 | 4.32 | 4.39 | |||||
Return On Equity % | 8.09 | 7.75 | 6.29 | 8.17 | 8.03 | |||||
Return on Common Equity | 8.09 | 7.79 | 6.48 | 8.22 | 8.29 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 10.13 | 10.75 | 9.39 | 11.41 | 11.87 | |||||
SG&A Margin | 5.42 | 5.25 | 5.05 | 6.38 | 7.48 | |||||
EBITDA Margin % | 5.9 | 6.38 | 5.24 | 5.87 | 5.07 | |||||
EBITA Margin % | 3.92 | 4.52 | 3.37 | 4.34 | 3.78 | |||||
EBIT Margin % | 3.26 | 3.8 | 2.76 | 3.91 | 3.5 | |||||
Income From Continuing Operations Margin % | 2.65 | 2.59 | 2.28 | 2.71 | 2.37 | |||||
Net Income Margin % | 2.65 | 2.54 | 2.24 | 2.6 | 2.34 | |||||
Net Avail. For Common Margin % | 2.65 | 2.54 | 2.24 | 2.6 | 2.34 | |||||
Normalized Net Income Margin | 2.38 | 2.47 | 2.22 | 2.64 | 2.32 | |||||
Levered Free Cash Flow Margin | 3.29 | 2.79 | 2.19 | 3.24 | -0.54 | |||||
Unlevered Free Cash Flow Margin | 3.39 | 2.9 | 2.28 | 3.33 | -0.46 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.15 | 1.17 | 1.2 | 1.35 | 1.47 | |||||
Fixed Assets Turnover | 3.14 | 3.36 | 3.49 | 4.27 | 5.05 | |||||
Receivables Turnover (Average Receivables) | 6.73 | 6.98 | 6.85 | 7.21 | 7.15 | |||||
Inventory Turnover (Average Inventory) | 25.4 | 25.97 | 25.16 | 23.72 | 21.5 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.5 | 1.73 | 1.78 | 1.61 | 1.54 | |||||
Quick Ratio | 1.29 | 1.53 | 1.54 | 1.32 | 1.22 | |||||
Operating Cash Flow to Current Liabilities | 0.2 | 0.13 | 0.18 | 0.41 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 54.24 | 52.28 | 53.27 | 50.75 | 51.05 | |||||
Days Outstanding Inventory (Average Inventory) | 14.37 | 14.05 | 14.51 | 15.43 | 16.98 | |||||
Average Days Payable Outstanding | 44.17 | 42.27 | 41.09 | 44.22 | 47.85 | |||||
Cash Conversion Cycle (Average Days) | 24.44 | 24.06 | 26.69 | 21.95 | 20.18 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 112.99 | 94.84 | 72.31 | 69.2 | 68.09 | |||||
Total Debt / Total Capital | 53.05 | 48.67 | 41.96 | 40.9 | 40.51 | |||||
LT Debt/Equity | 74.93 | 63.54 | 49.59 | 42.51 | 42.33 | |||||
Long-Term Debt / Total Capital | 35.18 | 32.61 | 28.78 | 25.12 | 25.18 | |||||
Total Liabilities / Total Assets | 63.28 | 59.01 | 54.17 | 56.28 | 57.02 | |||||
EBIT / Interest Expense | 19.43 | 21.98 | 18.7 | 28.87 | 26.86 | |||||
EBITDA / Interest Expense | 35.19 | 36.98 | 35.52 | 43.37 | 38.95 | |||||
(EBITDA - Capex) / Interest Expense | 26.32 | 31.43 | 29.3 | 37.78 | 23.14 | |||||
Total Debt / EBITDA | 6.35 | 5.27 | 5.13 | 4.09 | 4.08 | |||||
Net Debt / EBITDA | 2.6 | 1.55 | 1.5 | 0.8 | 1.32 | |||||
Total Debt / (EBITDA - Capex) | 8.49 | 6.2 | 6.22 | 4.69 | 6.87 | |||||
Net Debt / (EBITDA - Capex) | 3.47 | 1.82 | 1.82 | 0.92 | 2.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -1.37 | 6.3 | 0.9 | 17.71 | 21.29 | |||||
Gross Profit, 1 Yr. Growth % | -6.89 | 12.84 | -11.93 | 43.02 | 26.21 | |||||
EBITDA, 1 Yr. Growth % | -8.13 | 15.01 | -17.2 | 31.87 | 4.78 | |||||
EBITA, 1 Yr. Growth % | -11.25 | 22.44 | -24.59 | 51.22 | 5.78 | |||||
EBIT, 1 Yr. Growth % | -14.52 | 23.79 | -26.67 | 66.74 | 8.53 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 4.37 | 3.95 | -11.16 | 39.9 | 6.11 | |||||
Net Income, 1 Yr. Growth % | 4.37 | 1.91 | -10.92 | 36.89 | 9.05 | |||||
Normalized Net Income, 1 Yr. Growth % | -1.72 | 10.54 | -9.45 | 39.88 | 6.52 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 5.46 | 2.37 | -10.93 | 36.85 | 8.97 | |||||
Accounts Receivable, 1 Yr. Growth % | 1.67 | 3.23 | 2.43 | 20.99 | 23.46 | |||||
Inventory, 1 Yr. Growth % | -4.03 | 10.87 | 1.15 | 42.67 | 26.43 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.28 | -2.47 | -2.81 | -4.91 | 10.16 | |||||
Total Assets, 1 Yr. Growth % | 9.02 | 1.89 | -5.46 | 15.1 | 8.12 | |||||
Tangible Book Value, 1 Yr. Growth % | -2.79 | 13.07 | 9.31 | 17.12 | 5.88 | |||||
Common Equity, 1 Yr. Growth % | 3.1 | 8.56 | 5.84 | 9.89 | 6.47 | |||||
Cash From Operations, 1 Yr. Growth % | -0.05 | -37.71 | 15.15 | 227.24 | -71.99 | |||||
Capital Expenditures, 1 Yr. Growth % | 4.21 | -31.49 | -3.42 | -2.89 | 229.8 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -26.28 | -9.72 | -20.74 | 74.21 | -120.07 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -25.84 | -9.13 | -20.49 | 71.54 | -116.6 | |||||
Dividend Per Share, 1 Yr. Growth % | 100 | -50 | 0 | 12.5 | 33.33 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 0.61 | 2.39 | 3.57 | 8.98 | 19.48 | |||||
Gross Profit, 2 Yr. CAGR % | -0.97 | 2.5 | -0.31 | 12.23 | 34.36 | |||||
EBITDA, 2 Yr. CAGR % | -0.72 | 2.79 | -2.42 | 4.49 | 17.55 | |||||
EBITA, 2 Yr. CAGR % | 0.16 | 4.24 | -3.91 | 6.79 | 26.48 | |||||
EBIT, 2 Yr. CAGR % | -0.67 | 2.86 | -4.72 | 10.58 | 34.52 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 8.43 | 4.16 | -3.9 | 11.48 | 21.84 | |||||
Net Income, 2 Yr. CAGR % | 8.43 | 3.13 | -4.72 | 10.43 | 22.18 | |||||
Normalized Net Income, 2 Yr. CAGR % | 6.94 | 4.23 | 0.05 | 12.55 | 22.06 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 9.21 | 3.9 | -4.51 | 10.41 | 22.12 | |||||
Accounts Receivable, 2 Yr. CAGR % | 1.72 | 2.45 | 2.83 | 11.33 | 22.22 | |||||
Inventory, 2 Yr. CAGR % | 2.36 | 3.15 | 5.9 | 20.13 | 34.3 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -1.38 | -0.61 | -2.64 | -3.87 | 2.35 | |||||
Total Assets, 2 Yr. CAGR % | 4.37 | 5.39 | -1.86 | 4.32 | 11.56 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.52 | 4.84 | 11.17 | 13.15 | 11.36 | |||||
Common Equity, 2 Yr. CAGR % | 4.78 | 5.8 | 7.19 | 7.85 | 8.17 | |||||
Cash From Operations, 2 Yr. CAGR % | 87.91 | -21.1 | -15.3 | 94.12 | -4.26 | |||||
Capital Expenditures, 2 Yr. CAGR % | -34.15 | -15.5 | -18.65 | -3.16 | 78.96 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 25.2 | -18.42 | -15.41 | 17.51 | -40.86 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 31 | -17.91 | -15 | 16.79 | -46.64 | |||||
Dividend Per Share, 2 Yr. CAGR % | 41.42 | 0 | -29.29 | 6.07 | 22.47 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 0.74 | 2.47 | 1.89 | 8.08 | 12.94 | |||||
Gross Profit, 3 Yr. CAGR % | -2.9 | 3.43 | -2.56 | 12.43 | 16.71 | |||||
EBITDA, 3 Yr. CAGR % | -5.24 | 4.27 | -4.36 | 7.89 | 4.59 | |||||
EBITA, 3 Yr. CAGR % | -7.39 | 7.1 | -6.42 | 11.77 | 6.45 | |||||
EBIT, 3 Yr. CAGR % | -9.85 | 6.89 | -8.11 | 14.82 | 9.89 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -12.27 | 6.92 | -1.22 | 8.91 | 9.66 | |||||
Net Income, 3 Yr. CAGR % | -12.27 | 6.22 | -1.78 | 7.52 | 9.97 | |||||
Normalized Net Income, 3 Yr. CAGR % | -4.56 | 8.12 | -0.54 | 11.87 | 10.5 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -11.81 | 6.88 | -1.3 | 7.66 | 9.93 | |||||
Accounts Receivable, 3 Yr. CAGR % | 3.8 | 2.22 | 2.44 | 8.56 | 15.23 | |||||
Inventory, 3 Yr. CAGR % | -1.13 | 5.12 | 2.48 | 16.96 | 22.19 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -0.01 | -1.75 | -1.35 | -3.4 | 0.6 | |||||
Total Assets, 3 Yr. CAGR % | 3.54 | 3.54 | 1.64 | 3.5 | 5.57 | |||||
Tangible Book Value, 3 Yr. CAGR % | 1.52 | 6.61 | 6.31 | 13.12 | 10.67 | |||||
Common Equity, 3 Yr. CAGR % | 4.08 | 6.02 | 5.81 | 8.09 | 7.39 | |||||
Cash From Operations, 3 Yr. CAGR % | 8.51 | 30.05 | -10.5 | 32.9 | 1.82 | |||||
Capital Expenditures, 3 Yr. CAGR % | 3.74 | -33.28 | -11.65 | -13.71 | 45.7 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 2.84 | 12.27 | -19.2 | 7.62 | -34.8 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 2.38 | 15.96 | -18.78 | 7.42 | -39.05 | |||||
Dividend Per Share, 3 Yr. CAGR % | 25.99 | 0 | 0 | -17.45 | 14.47 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.52 | 2.64 | 1.86 | 5.03 | 8.6 | |||||
Gross Profit, 5 Yr. CAGR % | 0 | 2.02 | -1.88 | 6.87 | 10.8 | |||||
EBITDA, 5 Yr. CAGR % | -2.89 | 1.83 | -4.12 | 4.36 | 3.87 | |||||
EBITA, 5 Yr. CAGR % | -4.4 | 2.47 | -6.01 | 6.97 | 5.56 | |||||
EBIT, 5 Yr. CAGR % | -6.3 | 1.22 | -7.84 | 8.35 | 7.02 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -1.68 | -1.89 | -9.01 | 8.72 | 7.43 | |||||
Net Income, 5 Yr. CAGR % | -1.68 | -2.28 | -9.32 | 7.88 | 7.18 | |||||
Normalized Net Income, 5 Yr. CAGR % | -3.56 | 2.89 | -2.74 | 9.87 | 7.95 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -1.38 | -1.88 | -8.96 | 8.28 | 7.48 | |||||
Accounts Receivable, 5 Yr. CAGR % | 4.83 | 6.18 | 3.41 | 5.77 | 9.94 | |||||
Inventory, 5 Yr. CAGR % | 0.98 | 1.99 | 1.62 | 10.89 | 14.19 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 1.21 | -0.41 | -1.07 | -2.6 | 0.11 | |||||
Total Assets, 5 Yr. CAGR % | 2.86 | 3.16 | 1.35 | 3.85 | 5.5 | |||||
Tangible Book Value, 5 Yr. CAGR % | 7.06 | 7.54 | 5.28 | 9.18 | 8.3 | |||||
Common Equity, 5 Yr. CAGR % | 7.66 | 7.06 | 5.31 | 6.75 | 6.75 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.22 | 11.49 | -1.73 | 52.65 | -8.05 | |||||
Capital Expenditures, 5 Yr. CAGR % | -10.42 | -3.96 | -5.88 | -22.55 | 17.17 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 8.87 | 30.25 | -4.89 | 14.33 | -28.69 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 7.77 | 26.39 | -4.96 | 16.29 | -31.34 | |||||
Dividend Per Share, 5 Yr. CAGR % | 18.49 | 1.03 | 0 | 2.38 | 8.45 |
- Stock Market
- Equities
- 3353 Stock
- Financials Medical Ikkou Group Co.,Ltd.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















